Neurogene Inc.NGNENASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P53
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -1.13% |
| Q2 2025 | 6.32% |
| Q1 2025 | -18.74% |
| Q4 2024 | -12.41% |
| Q3 2024 | 2.07% |
| Q2 2024 | 26.59% |
| Q1 2024 | 26.65% |
| Q4 2023 | -155.15% |
| Q3 2023 | -24.03% |
| Q2 2023 | 31.19% |
| Q1 2023 | -33.15% |
| Q4 2022 | -15.98% |
| Q3 2022 | 21.57% |
| Q2 2022 | 20.58% |
| Q1 2022 | -16.78% |
| Q4 2021 | -47.43% |
| Q3 2021 | 40.21% |
| Q2 2021 | -2.48% |
| Q1 2021 | -37.10% |
| Q4 2020 | -1700.13% |
| Q3 2020 | 93.69% |
| Q2 2020 | -33.10% |
| Q1 2020 | -38.95% |
| Q4 2019 | 30.06% |
| Q3 2019 | -354.94% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 37.01% |
| Q3 2018 | -263.57% |
| Q2 2018 | 159.31% |
| Q1 2018 | -40.93% |
| Q4 2017 | 16.09% |
| Q3 2017 | -30.10% |
| Q2 2017 | 10.17% |
| Q1 2017 | -34.00% |
| Q4 2016 | -14.36% |
| Q3 2016 | 0.00% |